180 Life Sciences CORP

Forum Markets, through its subsidiary Eurus Aerospace Token I LLC, has acquired a CFM56-7B aircraft engine for $11.65 million and immediately leased it out.

Forum Markets, Inc. has acquired a CFM56-7B aircraft engine for $11.65 million, expanding its aviation portfolio and generating immediate lease revenue.

Forum Markets, Inc. has amended its Series B-3 Preferred Stock Purchase Agreement with Zippy, Inc., restructuring the 'Final Make Whole Amount' to a trifurcated framework with three separate measurement and payment dates.

Forum Markets, Incorporated announced an extension and amendment to its share repurchase program, reducing the aggregate authorization while adding flexibility for derivative transactions.

Forum Markets, Inc. reported first quarter 2026 financial results, highlighting entry into AI infrastructure financing and significant share repurchases, while updating its full-year AUM and revenue outlook.

Forum Markets, Incorporated announced an update on its share repurchase program, detailing the number of shares repurchased and outstanding.

Forum Markets, Inc. (formerly ETHZilla Corporation) filed its Form 10-Q for the quarter ended June 30, 2026, detailing a strategic pivot towards digital assets and RWA tokenization, reporting significant net losses and operational changes.

Forum Markets reports a net loss of $76.3 million for Q1 2026 as it transitions to a digital asset and RWA tokenization business model.

ETHZilla Corporation has shifted its core business to an Ethereum-focused treasury strategy, reporting a significant net loss in Q3 2025 despite substantial capital raises and the alleviation of going concern doubts.

180 Life Sciences Corp. reported a significant increase in net loss and cash burn for the first half of 2025, raising substantial doubt about its ability to continue as a going concern, as it pivots from biotechnology to online blockchain gaming.

180 Life Sciences reports a net loss for Q1 2025 while strategically shifting focus to the online gaming industry and managing legacy biotechnology assets.

180 Life Sciences Corp. reports a net loss for Q3 2024 but highlights a strategic move into the iGaming industry with the acquisition of a blockchain casino platform.

180 Life Sciences Corp. files an amendment to its annual report on Form 10-K to include required XBRL tagging for certain disclosures.

180 Life Sciences Corp. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted disclosures regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.

180 Life Sciences Corp. reports its annual results, highlighting a strategic shift towards the iGaming industry with the acquisition of a blockchain casino platform, while addressing ongoing financial challenges and legacy biotechnology programs.

180 Life Sciences Corp. has filed an amendment to its annual report to include previously omitted disclosures regarding directors, executive compensation, and related matters.

180 Life Sciences Corp., a clinical-stage biotech company, released its 2023 annual report, highlighting ongoing research and development efforts amidst financial constraints and a strategic review process.

Konstantin Lomashuk, a 10% owner of 180 Life Sciences Corp., sold 250,000 shares of common stock on July 21, 2026 for $6.00 per share.

Konstantin Lomashuk, a 10% owner of 180 Life Sciences Corp., sold 2,562 shares of common stock on July 15, 2026 for $6.30 per share.

Konstantin Lomashuk, a 10% owner of 180 Life Sciences Corp., sold 3,387 shares of common stock on July 9, 2026 for $6.15 per share.

Konstantin Lomashuk, a director and 10% owner of FORUM MARKETS Inc. (FRMM), reported the sale of 3,702 shares on July 7, 2026, and 1,100 shares on July 8, 2026.

Forum Markets Inc. director Angela Dalton has received a grant of 203,562 restricted stock units with vesting schedules extending through April 2027.

Michael Edwards, a Director at FORUM MARKETS Inc. (FRMM), has reported the acquisition of 203,562 shares of Common Stock, primarily through restricted stock units.

Forum Markets, Incorporated has announced its 2026 Annual Meeting of Stockholders, scheduled for August 19, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.

ETHZilla Corporation calls a Special Meeting to vote on removing a 20% exchange cap on senior secured convertible notes, potentially leading to significant dilution.

Ethzilla Corporation calls a special meeting to approve the issuance of common stock related to senior secured convertible notes, potentially exceeding 20% of outstanding shares.

ETHZilla Corporation announced significant changes to its board composition and executive compensation, including a director's resignation and new employment terms for its CEO.

ETHZilla Corporation calls a Special Meeting on October 7, 2025, to vote on electing a new director, approving multiple incentive plans, removing a Nasdaq exchange cap on convertible notes, and increasing authorized common stock.

180 Life Sciences Corp. is calling its stockholders to an annual meeting to vote on critical proposals including a reverse stock split, a tenfold increase in authorized common stock, and new equity incentive plans, primarily aimed at maintaining its Nasdaq listing and attracting talent.

180 Life Sciences Corp. is launching a best efforts offering of up to 7,092,198 units to raise up to $10 million, primarily to fund its new online blockchain casino operations.

180 Life Sciences Corp. has filed an amendment to its S-1 registration statement for the resale of up to 3,100,148 shares of common stock by selling stockholders.

180 Life Sciences Corp. plans to raise up to $10 million through a unit offering to support its newly acquired blockchain-based iGaming platform and for general corporate purposes.

180 Life Sciences Corp. has filed an amendment to its S-1 registration statement to allow a selling stockholder to resell up to 1,900,138 shares of common stock issuable upon exercise of warrants.

180 Life Sciences Corp. has filed a registration statement for the resale of up to 1.9 million shares of common stock by a selling stockholder, stemming from the exercise of warrants.

180 Life Sciences Corp. is offering up to 3,296,703 shares of common stock along with warrants to raise capital, while also addressing Nasdaq listing compliance and exploring strategic alternatives.

ETHZilla Corporation settled disputes with Elray Resources and Luxor Capital, agreeing to repurchase 1.318 million shares for $1 million, while Elray exercised warrants and subsequently sold shares.

Blair Jordan's beneficial ownership in 180 Life Sciences Corp. has fallen below 5% following new option grants and accelerated vesting of restricted stock.

Blair Jordan, CEO of 180 Life Sciences Corp., has updated his beneficial ownership to 31.3% of common stock, reflecting adjustments to restricted stock grants and new option awards, as detailed in an amended Schedule 13D filing.

Blair Jordan, CEO of 180 Life Sciences Corp., has significantly increased his beneficial ownership to 31.7% through accelerated restricted stock vesting, new option and restricted stock grants, and strategic voting agreements.

Blair Jordan, CEO of 180 Life Sciences Corp., has significantly increased his beneficial ownership to 30.2% of the company's common stock through a combination of restricted stock grants and new voting agreements with key shareholders.

Elray Resources, Inc., a significant shareholder in 180 Life Sciences Corp., converted 1 million shares of Series B Convertible Preferred Stock into 1.318 million common shares, increasing its beneficial ownership to 52.8% of the company's outstanding common stock.

Zippy, Inc. has disclosed beneficial ownership of 571,427 shares, representing 4.3% of Forum Markets Inc.'s common stock, as of April 20, 2026.

Brian James Pemble has amended his Schedule 13G filing to report beneficial ownership of 1,451,714 shares of Forum Markets, Incorporated common stock, representing 10.99% of the class.

Hudson Bay Capital Management LP and Sander Gerber have disclosed a 1.84% beneficial ownership stake in ETHZilla Corp, primarily through call options.

Zippy Inc. has disclosed a 7.1% beneficial ownership stake in ETHZilla Corp, holding 1,333,332 shares of common stock.

Brian Pemble has reported a beneficial ownership of 6.91% of ETHZilla Corp's common stock.

Steadfast Capital Management LP and its affiliates have reported a passive 4.5% beneficial ownership stake in ETHZilla Corp's common stock as of September 30, 2025.